Tag archief: English Only

IFF Announces Appointment of Brett Icahn and Richard Mulligan to Board of Directors

NEW YORK–(BUSINESS WIRE)– IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Brett Icahn and Richard Mulligan,...

Pure Lithium Opens New Chicago Headquarters, Advancing Commercialization of Its Lithium Metal Battery

CHICAGO–(BUSINESS WIRE)– Pure Lithium Corp., a disruptive vertically integrated lithium metal battery technology company, officially opened its new headquarters in Chicago’s Fulton Market district with...

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors

Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to License Global Rights to an...

NTT DATA Strengthens Global Insurance Leadership with Acquisition of Alchemy Technology Services

LONDON–(BUSINESS WIRE)– NTT DATA, a global leader in AI, digital business and technology services, today announced the acquisition of Alchemy Technology Services, a specialist insurance...

New Needle-Free Treatment Option for Life-Threatening Anaphylaxis, EURneffy®, Now Available in the UK

READING, England–(BUSINESS WIRE)– For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction.1,2 Yet from today, the UK’s...

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – OSAKA, Japan & WALTHAM, Mass.–(BUSINESS WIRE)– Ono Pharmaceutical Co., Ltd....

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT

With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2% Global Phase 3 MANEUVER study demonstrated...

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

– Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of...

Global Study Finds Most SAP Customers Favor Multi-Vendor Composable ERP for Faster Innovation, Including AI

Organizations using composable architectures with third-party support achieve above-average performance 83% of the time versus 27% for traditional approaches LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc....

Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio

Acquisition aims to strengthen Merck’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphere™ Protein A resin technology complements Merck’s existing biologics...

IFF to Release Third Quarter 2025 Results on Nov. 4, 2025

NEW YORK–(BUSINESS WIRE)– IFF (NYSE:IFF) today announced that it will release its third quarter 2025 earnings results following the market close on Tuesday, Nov. 4,...

Rimini Street to Report Third Quarter 2025 Financial Results on October 30, 2025

LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and innovation solutions, and the leading third-party...

Adtran launches Mosaic One Clarity to transform network operations with AI-based predictive maintenance and proactive assurance

News summary: Service providers face mounting operational strain from costly site visits and complex troubleshooting Adtran’s Mosaic One Clarity, built on its REAL AI platform,...

Symrise and Aplantex Confirm an Agreement to Establish a Partnership

MONTREAL–(BUSINESS WIRE)– Symrise AG (“Symrise”) and Aplantex Bio (“Aplantex”) agree on a partnership covering new technologies for accessing plant-based molecules as raw material once the...

Ant International’s WorldFirst Launches in Thailand to Offer Unified Global Account Service for Thai SMEs

WorldFirst has officially launched in Thailand through the partnership with 2C2P, offering Thai SMEs the innovative unified global account service to simplify international transactions and...